Workflow
中达安(300635) - 2023 Q3 - 季度财报
SinoDaanSinoDaan(SZ:300635)2023-10-26 16:00

Financial Performance - The company's revenue for Q3 2023 was CNY 196,576,225, representing a year-over-year increase of 25.32% compared to CNY 156,855,200 in the same period last year[5]. - The net profit attributable to shareholders for Q3 2023 was CNY 6,754,363, a significant decrease of 161.97% from CNY 10,899,350 in Q3 2022[5]. - The basic earnings per share for Q3 2023 was -0.0495, down 161.95% from CNY 0.0799 in the same quarter last year[5]. - Net profit for the current period was ¥8,173,664.97, a decrease of 65.7% from ¥23,821,596.69 in the previous period[21]. - The company’s total profit for the current period was ¥8,880,242.52, down from ¥26,058,543.54 in the previous period[21]. Cash Flow - The net cash flow from operating activities for the year-to-date period increased by 48.92%, reaching CNY 8,916,441 compared to CNY 6,000,000 in the previous year[5]. - The company reported a net cash flow from operating activities of -¥8,916,441.54, an improvement from -¥17,456,186.92 in the previous period[22]. - Net cash flow from financing activities increased by 284.39% to ¥11,563,363.06, primarily due to increased long-term bank borrowings compared to the same period last year[9]. - In Q3 2023, the net cash flow from financing activities was ¥11,563,363.06, an increase from ¥3,008,213.71 in Q3 2022, indicating improved financing performance[23]. Assets and Liabilities - Total assets as of September 30, 2023, were CNY 1,228,771,543.66, reflecting a 4.43% increase from CNY 1,176,657,924.89 at the end of the previous year[5]. - The company's total liabilities increased to CNY 778,610,315.03 from CNY 652,503,461.23, reflecting a growth of approximately 19.3%[17]. - The company's equity attributable to shareholders decreased by 15.60%, amounting to CNY 424,067,213.90 compared to CNY 502,435,105.16 at the end of the previous year[5]. - Cash and cash equivalents decreased to CNY 120,991,878.82 from CNY 143,978,308.49, a reduction of approximately 16.0%[16]. Shareholder Information - The largest shareholder, Jinan Likong Disen Equity Investment Partnership, holds 14,031,261 shares, accounting for 10.29% of total shares[10]. - Wu Junye, a significant shareholder, holds 9,584,148 shares, representing 9.37% of total shares[10]. - The total number of shareholders at the end of the reporting period is 11,549, with no preferred shareholders reported[11]. - The company has a total of 3,328,425 shares under lock-up for executive management, which cannot exceed 15% of their total holdings during their tenure[11]. Operational Changes - The company has undergone adjustments in accounting policies due to mergers and changes in accounting standards effective from January 1, 2023[5]. - The company has not reported any new strategies or product developments in this quarter[10]. - There are no indications of market expansion or mergers and acquisitions in the current report[10]. Expenses and Investments - Sales expenses increased by 81.35% to ¥11,484,173.74, mainly due to increased market development expenses compared to the same period last year[9]. - Research and development expenses increased to ¥36,845,041.89, up from ¥32,703,739.78 in the previous period, reflecting a focus on innovation[19]. - Total investment activities resulted in a net cash outflow of -¥24,165,167.37, compared to -¥5,802,197.85 in the previous period, indicating increased investment efforts[22]. Other Financial Metrics - Non-recurring gains and losses for Q3 2023 totaled CNY 10,871,085.29, compared to CNY 9,999,692.37 for the year-to-date period[6]. - The company has not classified any non-recurring gains and losses as regular gains and losses, maintaining compliance with disclosure requirements[7]. - Deferred tax assets increased from ¥60,453,709.09 to ¥64,070,858.14 due to the implementation of new accounting standards, reflecting an adjustment of ¥3,066,160.71[25]. - Deferred tax liabilities rose significantly from ¥384,053.02 to ¥3,278,499.35, with an adjustment of ¥2,894,446.33[25].